Chemotherapy Induced Neuropathy: Update on Treatment Options That Really Work 1901

Thursday, October 30, 2025

8:15 AM - 9:15 AM

Location: ROOM: Buckingham Room >>> DIRECTIONS: Lobby Level >>> From the Main Elevator Bank, proceed right toward the FedEx Office. Turn right just before the FedEx Office and continue down the corridor. Turn right before the Continental Foyer. The Buckingham Room is located to your right, just before the Men's Room.

Presenter(s)

Sara Christensen Holz

Associate professor
University of Wisconsin School of Medicine and Public Health
Madison, WI, United States

Slides Slides
Lisa Dussault, OTR/CLT

Occupational Therapist - oncology rehabilitation
UW Health
Madison, Wisconsin, United States
Joanna Collins, OT/L

Rehabilitation Oncology Program Educator, Occupational Therapy Supervisor.
Northside Hospital
Smyrna, GA, United States
Lynn R. Tanner, PT, PhD (she/her/hers)

Scientific Director of Physical Medicine and Rehabilitation
Children's Minnesota
Eagan, MN, United States
Laura Prince, MD

Attending physician
Advocate Medical Group
Chicago, IL, United States

This symposium will include a brief review of the pathophysiolgoy and epidemiology of chemotherapy induced peripheral neuropathy. A case based format will be utilized to review current evidence based treatment options including therapy techniques, medication and interventional therapies.

Learning Objectives:

Describe prevalence and diagnosis of chemotherapy induced neuropathy (CIPN)
Describe therapy techniques to manage CIPN symptoms including desensitization and taping
Describe assessment and most common intervention in the pediatric population
Understand role of capsacian and nerve blocks for CIPN